Jeffrey G. Stoll & Uma Yasothan
Abstract
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease that affects ~0.8% of the adult population worldwide.
Artrite Reumatóide
- Effect of Prednisone on Type I Interferon Signature in Rheumatoid Arthritis
- Etanercept for patients with RA: more is not always better
- Deficient spontaneous in vitro apoptosis and increased tmTNF reverse signaling-induced apoptosis of monocytes predict suboptimal therapeutic response of rheumatoid arthritis to TNF inhibition
- Towards the elucidation of the true impact of adipocytokines on cardiovascular risk in rheumatoid arthritis
- What autoantibody tests should become widely available to help scleroderma diagnosis and management?
- Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis
- New Rheumatoid Arthritis Guidelines Released
- Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
- A New Chapter in Rheumatoid Arthritis Therapeutics
- Head-to-Head Comparison of Subcutaneous Abatacept Versus Adalimumab for Rheumatoid Arthritis
- Palindromic Rheumatism With Positive Anticitrullinated Peptide/Protein Antibodies Is Not Synonymous With Rheumatoid Arthritis. A Longterm Followup Study
- Safety and efficacy of ARA290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double blind, pilot study.
- Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients With Active Rheumatoid Arthritis – Rheumatology
- Abatacept Use After Failure of Multiple Biologic Agents in Patients With Severe Rheumatoid Arthritis
- Can Flare Be Predicted in DMARD Treated RA Patients in Remission, and Is It Important?
- Multibiomarker Disease Activity Test Complements Clinical Assessment in Rheumatoid Arthritis CME
- The effect of smoking or alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis
- The Pathogenesis of Rheumatoid Arthritis
- Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration
- Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study
- Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
- 2010 Rheumatoid Arthritis Classification Criteria. An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
- The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies
- Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression
- Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared to the general population
- Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial
- Novo tratamento para a artrite reumatóide mostra-se eficaz
- Treatment of rheumatoid arthritis: state of the art 2009
- Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
- Rheumatoid arthritis and smoking: putting the pieces together
- Etanercept for patients with RA: more is not always better